bpc 157 human clinical trial randomized placebo BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded Regeneration or Risk? A Narrative

Protein farnesylation is upregulated in Alzheimers human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimers model mice

doi: 10.1016/j.bmcl.2018.01.058

Stress & sleep: Manage stress and prioritize high-quality sleep, since both strongly influence cognition and mood

TB-500 reduces glial scarring, promotes repair cell migration, and supports angiogenesis through complementary mechanisms

vademecum.es van Loon SL, Wilbik AM, Kaymak U, van den Heuvel ER, Scharnhorst V, Boer AK

Medicare contractors actively scrutinize accounts with very high 20610 billing frequency, especially for the same joint, and elevated utilization triggers additional documentation requests (ADRs) and potential targeted probe and educate (TPE) reviews